Idorsia (IDRSF) to Release Quarterly Earnings on Thursday

Idorsia (OTCMKTS:IDRSF) will likely be issuing its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share and revenue of $19.82 million for the quarter.

Idorsia Price Performance

IDRSF opened at $0.75 on Friday. The business has a fifty day moving average price of $0.91 and a 200 day moving average price of $1.58. Idorsia has a 12 month low of $0.70 and a 12 month high of $2.88.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.